Vectura headquarters in Chippenham, UK (Vectura)
Vectura leans into new role as inhalation CDMO post-asthma flop with plant expansion
Two years after its leading asthma therapy flopped in a Phase III study, the UK’s Vectura switched gears to focus on manufacturing inhalable drugs …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
